In this brief report we present the case of a 53 year old man with a very debilitating Generalized Anxiety Disorder successfully treated with tranylcypromine. After several failed treatment attempts following international guidelines recommendations over the course of one year and a half, tranylcypromine was prescribed which led to effective and sustained remission of anxiety symptoms for this patient. We also briefly explore treatment options for resistant cases of generalized anxiety disorder, given the major negative impacts of untreated GAD in a person\u27s daily functioning and quality of life
Generalized anxiety disorder (GAD) is common in community and clinical settings. The individual and ...
Generalized anxiety disorder (GAD) is a common and debilitating medical condition, associated with s...
Generalized anxiety disorder (GAD) is a chronic and disabling condition. The aim of this study was t...
In this brief report we present the case of a 53 year old man with a very debilitating Generalized A...
Objective: Pharmacological treatment of anxiety disorders is an active research field and Selective ...
Introduction: Selective serotonin reuptake inhibitors (SSRIs) and serotonine reuptake Inhibitors (SN...
Background: Generalised anxiety disorder (GAD) is a common anxiety disorder associated with social a...
Three patients, a woman aged 70, a man aged 74 and a woman aged 78 years, all using tranylcypromine,...
Gabapentin is frequently used in the treatment of anxiety disorders. However, there are no randomize...
BACKGROUND: Monoamine oxidase (mao)-inhibitors are often prescribed in patients suffering from treat...
Purpose/Background Despite several decades of research, there are no US Food and Drug Administration...
Narong Maneeton,1 Benchalak Maneeton,1 Pakapan Woottiluk,2 Surinporn Likhitsathian,1 Sirijit Su...
OBJECTIVE: To investigate the efficacy and acceptability of antidepressants in the treatment of gene...
Background Pharmacological treatments have been successfully used to treat Generalized Anxiety Disor...
A previous review summarized what was then known about the potential role of pregabalin in the treat...
Generalized anxiety disorder (GAD) is common in community and clinical settings. The individual and ...
Generalized anxiety disorder (GAD) is a common and debilitating medical condition, associated with s...
Generalized anxiety disorder (GAD) is a chronic and disabling condition. The aim of this study was t...
In this brief report we present the case of a 53 year old man with a very debilitating Generalized A...
Objective: Pharmacological treatment of anxiety disorders is an active research field and Selective ...
Introduction: Selective serotonin reuptake inhibitors (SSRIs) and serotonine reuptake Inhibitors (SN...
Background: Generalised anxiety disorder (GAD) is a common anxiety disorder associated with social a...
Three patients, a woman aged 70, a man aged 74 and a woman aged 78 years, all using tranylcypromine,...
Gabapentin is frequently used in the treatment of anxiety disorders. However, there are no randomize...
BACKGROUND: Monoamine oxidase (mao)-inhibitors are often prescribed in patients suffering from treat...
Purpose/Background Despite several decades of research, there are no US Food and Drug Administration...
Narong Maneeton,1 Benchalak Maneeton,1 Pakapan Woottiluk,2 Surinporn Likhitsathian,1 Sirijit Su...
OBJECTIVE: To investigate the efficacy and acceptability of antidepressants in the treatment of gene...
Background Pharmacological treatments have been successfully used to treat Generalized Anxiety Disor...
A previous review summarized what was then known about the potential role of pregabalin in the treat...
Generalized anxiety disorder (GAD) is common in community and clinical settings. The individual and ...
Generalized anxiety disorder (GAD) is a common and debilitating medical condition, associated with s...
Generalized anxiety disorder (GAD) is a chronic and disabling condition. The aim of this study was t...